Iron(II) gluconate: Difference between revisions

Iron(II) gluconate
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

VisualWikitext

Revision as of 16:46, 30 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Iron(II) gluconate is a mineral that is FDA approved for the treatment of iron deficiency anemia,. Common adverse reactions include .

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Hemodialysis - Iron deficiency anemia, During epoetin therapy.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Iron(II) gluconate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Iron(II) gluconate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Iron(II) gluconate in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Iron(II) gluconate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Iron(II) gluconate in pediatric patients.

Contraindications

There is limited information regarding Iron(II) gluconate Contraindications in the drug label.

Warnings

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Do not take within 2 hours of taking oral tetracycline antibiotics, since oral iron products tend to interfere with absorption of tetracycline. May cause gastrointestinal discomfort, nausea, constipation or diarrhea. If you are pregnant or nursing a baby, seek advice of a health professional before using this product. U.S. Consumer Product Safety Commission requires that iron-containing medicines and vitamins with iron be packaged in child-resistant closures. Parents should always properly resecure safety closures.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Iron(II) gluconate in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Iron(II) gluconate in the drug label.

Drug Interactions

There is limited information regarding Iron(II) gluconate Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Iron(II) gluconate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Iron(II) gluconate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Iron(II) gluconate with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Iron(II) gluconate with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Iron(II) gluconate with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Iron(II) gluconate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Iron(II) gluconate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Iron(II) gluconate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Iron(II) gluconate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Iron(II) gluconate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Iron(II) gluconate in patients who are immunocompromised.

Administration and Monitoring

Administration

Oral

Intravenous

Monitoring

There is limited information regarding Monitoring of Iron(II) gluconate in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Iron(II) gluconate in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Iron(II) gluconate in the drug label.

Pharmacology

There is limited information regarding Iron(II) gluconate Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Iron(II) gluconate Mechanism of Action in the drug label.

Structure

File:Iron(II) gluconate01.png

This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Iron(II) gluconate in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Iron(II) gluconate in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Iron(II) gluconate in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Iron(II) gluconate in the drug label.

How Supplied

There is limited information regarding Iron(II) gluconate How Supplied in the drug label.

Storage

Store at 20° to 25°C (68° to 77°F)

Images

Drug Images

{{#ask: Page Name::Iron(II) gluconate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Iron(II) gluconate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Iron(II) gluconate in the drug label.

Precautions with Alcohol

Alcohol-Iron(II) gluconate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

FERROUS GLUCONATE®^[1]

Look-Alike Drug Names

A® — B®^[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ "FERROUS GLUCONATE- ferrous gluconate tablet".
↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject:

 |Page Name=Iron(II) gluconate
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Iron(II) gluconate
 |Label Name=Iron(II) gluconate11.png

}}

{{#subobject:

 |Label Page=Iron(II) gluconate
 |Label Name=Iron(II) gluconate11.png

}}

[1] "FERROUS GLUCONATE- ferrous gluconate tablet".

[www.ismp.org-2] "http://www.ismp.org". External link in |title= (help)

[1]

[2]

@@ Line 1: / Line 1: @@
 {{DrugProjectFormSinglePage
+|genericName=ferrous gluconate
 |aOrAn=a
+|drugClass=[[mineral]]
 |indicationType=treatment
-|hasBlackBoxWarning=Yes
+|indication=iron deficiency anemia,
 |adverseReactions=<!--Black Box Warning-->
 |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
@@ Line 12: / Line 14: @@
 <!--FDA-Labeled Indications and Dosage (Adult)-->
-|fdaLIADAdult======Condition1=====
+|fdaLIADAdult=* Hemodialysis - Iron deficiency anemia, During epoetin therapy.
+|offLabelAdultGuideSupport=
-* Dosing Information
-:* Dosage
-=====Condition2=====
-* Dosing Information
-:* Dosage
-=====Condition3=====
-* Dosing Information
-:* Dosage
-=====Condition4=====
-* Dosing Information
-:* Dosage
-<!--Off-Label Use and Dosage (Adult)-->
-<!--Guideline-Supported Use (Adult)-->
-|offLabelAdultGuideSupport======Condition1=====
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
 There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Non–Guideline-Supported Use (Adult)-->
-|offLabelAdultNoGuideSupport======Condition1=====
+|offLabelAdultNoGuideSupport=
-* Dosing Information
-:* Dosage
-=====Condition2=====
 There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
@@ Line 69: / Line 27: @@
 <!--FDA-Labeled Indications and Dosage (Pediatric)-->
-|fdaLIADPed======Condition1=====
+|fdaLIADPed=
-* Dosing Information
-:* Dosage
-=====Condition2=====
 There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
@@ Line 82: / Line 33: @@
 <!--Guideline-Supported Use (Pediatric)-->
-|offLabelPedGuideSupport======Condition1=====
+|offLabelPedGuideSupport=
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
 There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Non–Guideline-Supported Use (Pediatric)-->
-|offLabelPedNoGuideSupport======Condition1=====
+|offLabelPedNoGuideSupport=
-* Dosing Information
-:* Dosage
-=====Condition2=====
 There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Contraindications-->
-|contraindications=* Condition1
+|contraindications=
 <!--Warnings-->
-|warnings=* Description
+|warnings=* Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
+* Do not take within 2 hours of taking oral tetracycline antibiotics, since oral iron products tend to interfere with absorption of tetracycline. May cause gastrointestinal discomfort, nausea, constipation or diarrhea. If you are pregnant or nursing a baby, seek advice of a health professional before using this product. U.S. Consumer Product Safety Commission requires that iron-containing medicines and vitamins with iron be packaged in child-resistant closures. Parents should always properly resecure safety closures.
-====Precautions====
-* Description
-<!--Adverse Reactions-->
-<!--Clinical Trials Experience-->
 |clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
-=====Body as a Whole=====
-=====Cardiovascular=====
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
-<!--Postmarketing Experience-->
 |postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
-=====Body as a Whole=====
-=====Cardiovascular=====
+|drugInteractions=
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
-<!--Drug Interactions-->
-|drugInteractions=* Drug
-:* Description
 <!--Use in Specific Populations-->
@@ Line 269: / Line 76: @@
 |monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
-* Description
 <!--IV Compatibility-->
@@ Line 275: / Line 82: @@
 <!--Overdosage-->
-|overdose====Acute Overdose===
+|overdose=
-====Signs and Symptoms====
-* Description
-====Management====
-* Description
-===Chronic Overdose===
 There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
@@ Line 293: / Line 90: @@
 <!--Drug box 2-->
 |drugBox=<!--Mechanism of Action-->
-|mechAction=*
+|mechAction=
 <!--Structure-->
-|structure=*
+|structure=
 : [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
@@ Line 313: / Line 110: @@
 <!--How Supplied-->
-|howSupplied=*
+|storage=* Store at 20° to 25°C (68° to 77°F)
 |packLabel=<!--Patient Counseling Information-->
 |fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
@@ Line 321: / Line 118: @@
 <!--Brand Names-->
-|brandNames=* ®<ref>{{Cite web | title =  | url = }}</ref>
+|brandNames=* FERROUS GLUCONATE®<ref>{{Cite web | title = FERROUS GLUCONATE- ferrous gluconate tablet  | url =http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=304fdee6-0290-4717-be3d-b367bec7e411 }}</ref>
 <!--Look-Alike Drug Names-->

Iron(II) gluconate: Difference between revisions

Revision as of 16:46, 30 March 2015

Disclaimer

Overview

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Non–Guideline-Supported Use

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Non–Guideline-Supported Use

Contraindications

Warnings

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

Drug Interactions

Use in Specific Populations

Pregnancy

Labor and Delivery

Nursing Mothers

Pediatric Use

Geriatic Use

Gender

Race

Renal Impairment

Hepatic Impairment

Females of Reproductive Potential and Males

Immunocompromised Patients

Administration and Monitoring

Administration

Monitoring

IV Compatibility

Overdosage

Pharmacology

Mechanism of Action

Structure

Pharmacodynamics

Pharmacokinetics

Nonclinical Toxicology

Clinical Studies

How Supplied

Storage

Images

Drug Images

Package and Label Display Panel

Patient Counseling Information

Precautions with Alcohol

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

Navigation menu